An increasing proportion of patients with heart failure receive a combination of four medications shown to improve prognosis ...

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific renoprotective ...

The use of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in people with congestive heart failure (CHF) and renal dysfunction is poorly studied. Berger and ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...

The Toyota Land Cruiser 70 Series, widely known as the Troopy, is one of the most respected utility vehicles ever built.

In a phase 2 trial of a novel antihypertensive agent, multiple doses lowered plasma angiotensinogen to a greater extent than a single dose, but did not provide further blood pressure lowering, ...

Discover 9 important ibuprofen interactions to avoid. Learn which medications, supplements, foods, and alcohol can cause ...

A health explainer details how specific foods and beverages interact with blood pressure therapy, emphasizing safety implications. It outlines interactions between grapefruit and calcium channel ...

Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"-offering insights into a company's pipeline ...

Akebia Therapeutics is back in focus after analysts trimmed their fair value estimate from US$5.00 to US$4.40, aligning with ...

Kardigan(TM), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced ...